Immunologists across fourteen university medical centers have begun enrolling volunteers for the largest broad-spectrum respiratory vaccine trial in history.
Advertisement
Universal mRNA Antiviral Platform Enters Phase III Multicenter Clinical Trials
Researchers target conserved viral proteins to provide broad-spectrum immunity against seasonal and emerging respiratory strains.
Bureau Correspondent
Published
Reading Time
1 min read
Advertisement
